Glenzocimab Reference: HY-P99644 Glenzocimab (ACT017) is a Fab fragment of humanized anti-GPVI monoclonal antibody. Glenzocimab inhibits collagen-induced platelet aggregation. Glenzocimab has the potential for the research of acute ischemic stroke.
Normal Mouse Serum Reference: BMS0070_2ml High quality Normal mouse serum processed from non-immunized normal adult mouses is used as a blocking agent or as a negative control for immunoassays.
Pepinemab Reference: HY-P99407 Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular processes. Pepinemab can be used in the study of various neurodegenerative diseases such as Alzheimer's disease by blocking the activity of SEMA4D.
Normal Horse Serum Reference: BMS0150_2ml High quality Normal horse serum processed from non-immunized normal adult horses is used as a blocking agent or as a negative control for immunoassays.
Bepranemab Reference: HY-P99471 Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research.
Normal Chicken Serum Reference: BMS0030_2ml High quality Normal chicken serum processed from non-immunized normal adult chickens is used as a blocking agent or as a negative control for immunoassays.
Efgivanermin alfa Reference: HY-P99907 Efgivanermin alfa is an active peptide. Efgivanermin alfa can be used for various biochemical studies.
Normal Guinea pig Serum Reference: BMS0120_2ml High quality Normal guinea pig serum processed from non-immunized normal adult guinea pigs is used as a blocking agent or as a negative control for immunoassays.